Trials / Sponsors / PD Dr. med. Volker Heinemann
PD Dr. med. Volker Heinemann
Academic / Other · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Optimization of Individualized Therapy for CRCs With Secondary RESISTance Towards Anti-EGFR Targeted Therapy U Colo-rectal Cancer, RAS Wild-type, UICC III | — | 2017-01-01 |
| Unknown | Afatinib and Gemcitabine/Nab-paclitaxel in Metastatic Pancreatic Cancer Metastatic Pancreatic Cancer | Phase 1 | 2016-09-01 |
| Unknown | Afatinib as Cancer Therapy for Exocrine Pancreatic Tumours Focus of Study Instead | Phase 2 | 2013-04-01 |
| Unknown | Panitumumab After Resection of Liver Metastases From Colorectal Cancer in KRAS Wild-type Patients Colorectal Cancer, KRAS Wildtype, After Resection of Liver Metastases | Phase 2 | 2011-08-01 |
| Unknown | 5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treat Neoplasm Metastasis, Colorectal Cancer | Phase 3 | 2007-01-01 |
| Unknown | Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine Pancreatic Cancer | Phase 3 | 2006-06-01 |